Pharmaceutical - Mergers & Acquisitions


Current filters:

Mergers & Acquisitions

Popular Filters

651 to 654 of 654 results

GlaxoSmithKline divests batch of OTC brands for $660 million, but still more to go


The widely expected sale of UK pharma giant GlaxoSmithKline (LSE: GSK) non-prescription brands was confirmed…

GlaxoSmithKlineMergers & AcquisitionsPharmaceutical

Takeda boosts oncology pipeline with acquisition


Japan’s largest drugmaker Takeda Pharmaceutical (TYO: 4502), via a US subsidiary, has entered into…

IntellikineMergers & AcquisitionsOncologyPharmaceuticalTakeda Pharmaceuticals

ISTA Pharma rejects Valeant’s advances; Alexza could be for sale


Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) has entered into another…

AdasuveAlexza PharmaceuticalISTA PharmaceuticalMergers & AcquisitionsNeurologicalOphthalmicsPharmaceuticalValeant Pharmaceuticals

651 to 654 of 654 results

Back to top